There are few hypoxanthine manufacturers and product supply is limited.
Hypoxanthine, also known as 6-hydroxypurine, is a metabolite of nucleosides and is present in transfer ribonucleic acid. It is an important alkaloid purine and participates in regulating some physiological functions of the human body. Hypoxanthine is in its normal state as white needle-like crystals and can decompose at 150°C. Hypoxanthine is an important raw material for the preparation of 6-mercaptopurine. 6-mercaptopurine is a synthetic analog of natural purine base. It is mainly used to slow down the growth of cancer cells and is suitable for adults and children with acute lymphoblastic leukemia and chronic Myeloid leukemia has a good therapeutic effect.
At present, there are relatively few companies that can produce hypoxanthine. Hypoxanthine is a very important biochemical reagent and is widely used in medicine, agricultural chemicals and other fields. Its downstream derivatives are mainly adenine and 6-mercapto. Purine, 6-benzylaminopurine, acyclovir, 6-mercaptopurine (monohydrate), 6-benzylaminopurine, etc., respectively, are vitamin B4, white blood cell specific drugs, plant growth promoters, and herpes disease treatment drugs , the raw materials for the production of anti-tumor drug products have an irreplaceable role, so the supply of hypoxanthine products is limited and a supply bottleneck occurs.
According to 《China 2022-2027 released by the Industrial Research Center Hypoxanthine industry market in-depth research and development prospect forecast report》 shows that hypoxanthine in China There are only more than 20 manufacturing companies, with a total output of only about 1,000 tons in 2021. The companies with larger production scales are Xinxiang Tuoxin Pharmaceutical Co., Ltd., Xinxiang Ruicheng Technology Co., Ltd., and Luoyang Desheng Biotechnology Co., Ltd. In addition, Shanghai Yuanye Biotechnology Co., Ltd. and Shanghai Future Industrial Co., Ltd. can also provide small amounts of hypoxanthine products.
my country’s hypoxanthine industry has problems such as backward technical and technological level, slow industrialization process, and relatively single downstream applications. To this end, on the one hand, the state should encourage scientific research institutes and enterprises to research and develop related technologies, establish hypoxanthine-related research projects, and provide financial rewards or tax incentives to enterprises that realize the transformation of hypoxanthine technological achievements, so as to promote the development of hypoxanthine in my country. development of the industry; on the other hand, the country should continue to promote the downstream research and development applications of hypoxanthine and expand the application scope of hypoxanthine products. In addition, enterprises should also actively respond to the national call for the development of the pharmaceutical and chemical industry, lead enterprise development with innovation, increase investment in hypoxanthine-related research, and continuously improve production technology levels.
Industrial researchers believe that hypoxanthine is a fine chemical product and is supported by national policies and has good development prospects. Therefore There are many potential entrants in the industry, but due to technical barriers, many potential entrants are blocked. As hypoxanthine-related research continues to deepen, companies will continue to break through technical bottlenecks and enter the field of hypoxanthine in the future. If existing manufacturing companies fail to continue to make progress in technological innovation, market expansion, etc., and fail to maintain leading market share, they will face greater market competition pressure.
微信扫一扫打赏
